Press release
Oropharyngeal cancer Pipeline Appears Robust With 10+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
In the Oropharyngeal Cancer Pipeline Report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, Oropharyngeal Cancer NDA approvals (if any), and product development activities comprising the technology, Oropharyngeal Cancer collaborations, licensing, mergers and acquisition, funding, designations and other product related details.
Key takeaways from the Oropharyngeal Cancer Pipeline Report
• Oropharyngeal Cancer Pipeline report offers a comprehensive analysis of 10+ companies and 10+ therapies.
• The leading Oropharyngeal Cancer Companies includes AstraZeneca, ISA Pharmaceuticals, Pfizer, Bristol Myers Squibb, Advaxis, PDS Biotechnology, Debiopharm, Merck KGaA, Regeneron Pharmaceuticals/Sanofi, and others.
• Promising Oropharyngeal Cancer Pipeline Therapies includes Transoral robotic surgery, Transoral ultrasound, Nivolumab Injection, Radiotherapy (RT), GC4419, ADXS11-001 (ADXS-HPV), Carboplatin, Paclitaxel, NBTXR3 activated by IMRT, Nab-paclitaxel, and others.
• The Oropharyngeal Cancer Companies and academics are working to assess challenges and seek opportunities that could influence Oropharyngeal cancer R&D. The Oropharyngeal Cancer pipeline therapies under development are focused on novel approaches to treat/improve Oropharyngeal Cancer.
Explore more information on the latest breakthroughs in the Oropharyngeal Cancer treatment landscape of the report and Oropharyngeal Cancer Pipeline Outlook @ https://www.delveinsight.com/sample-request/oropharyngeal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Oropharyngeal Cancer Overview
Oropharyngeal Cancer is cancer in the oropharynx, which is the middle part of your throat (pharynx). The oropharynx includes the back one-third of the tongue, tonsils, soft palate and the side and back walls of the throat. Oropharyngeal Cancer is a type of head and neck cancer that accounts for about 18,000 newly diagnosed cases in the U.S. every year. Most oropharyngeal cancers are squamous cell carcinomas, meaning that the cancer is affecting your squamous cells, which are thin flat cells found in the lining of most of your organs. And although rare, lymphoma, or cancer affecting cells in the lymphatic system, can also occur at the base of the tongue and tonsils, which are made up of lymph tissue. Symptoms include a sore throat that doesn't go away; a lump in the throat, mouth or neck; coughing up blood; white patch in the mouth and other symptoms. The stages of oropharyngeal cancer span from Stage I (best prognosis) to Stage IV (worst prognosis).
Oropharyngeal Cancer Emerging Drugs Profile
• Cisplatin: AstraZeneca
Cisplatin works by stopping the cancer cells from multiplying. It does this by binding together the strands of the cells' genetic material, DNA. Cisplatin binds to the N7 reactive center on purine residues and as such can cause deoxyribonucleic acid (DNA) damage in cancer cells, blocking cell division and resulting in apoptotic cell death. The drug is being evaluated in Phase III clinical trials in combination with Durvalumab for the treatment of patients with Oropharyngeal cancer.
• ISA101B: ISA Pharmaceuticals
ISA101 consists of 12 synthetic long peptides (25 to 35 amino acids long) derived from the E6 and E7 oncogenic proteins of the HPV 16 virus, a strain responsible for over 50% of human cervical cancers and cervical intra-epithelial neoplasias, more than 85% of HPV-positive head and neck cancers, and similar substantial percentages of other premalignant and malignant HPV-induced lesions (such as VIN, vulvar cancer, AIN and anal cancer). It is currently administered either subcutaneously or intradermally. The drug is currently in Phase II stage of development for the treatment of patients with Oropharyngeal cancer.
Request a sample and discover the recent advances in Oropharyngeal Cancer Pipeline Therapies, visit Oropharyngeal Cancer Treatment Landscape @ https://www.delveinsight.com/sample-request/oropharyngeal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Oropharyngeal Cancer Pipeline Therapeutics Assessment
There are approx. 10+ key companies which are developing the therapies for Oropharyngeal Cancer. The companies which have their Oropharyngeal Cancer drug candidates in the most advanced stage, i.e. Phase III include, AstraZeneca.
Oropharyngeal Cancer Pipeline Therapeutics Segmentation
Phases
• Late stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I) along with the details of
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Route of Administration
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical
Molecule Type
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type
Get to know more information about the Oropharyngeal Cancer Emerging Drugs and Companies of the report @ https://www.delveinsight.com/sample-request/oropharyngeal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Oropharyngeal Cancer Pipeline Report
• Coverage- Global
• Oropharyngeal Cancer Companies- AstraZeneca, ISA Pharmaceuticals, Pfizer, Bristol Myers Squibb, Advaxis, PDS Biotechnology, Debiopharm, Merck KGaA, Regeneron Pharmaceuticals/Sanofi, and others.
• Oropharyngeal Cancer Pipeline Therapies- Transoral robotic surgery, Transoral ultrasound, Nivolumab Injection, Radiotherapy (RT), GC4419, ADXS11-001 (ADXS-HPV), Carboplatin, Paclitaxel, NBTXR3 activated by IMRT, Nab-paclitaxel, and others.
• Oropharyngeal Cancer Pipeline Segmentation: Product Type, Mechanism of Action, Route of Administration, Molecule Type
Table of Content
1. Introduction
2. Oropharyngeal Cancer Executive Summary
3. Oropharyngeal Cancer Overview
4. Oropharyngeal Cancer Pipeline Therapeutics
5. Oropharyngeal Cancer Pipeline Therapeutic Assessment
6. Oropharyngeal Cancer - DelveInsight's Analytical Perspective
7. In-depth Commercial Assessment
8. Oropharyngeal Cancer Collaboration Deals
9. Late Stage Products (Phase III)
10. Cisplatin: AstraZeneca
11. Drug profiles in the detailed report…..
12. Mid Stage Products (Phase II)
13. ISA101B: ISA Pharmaceuticals
14. Drug profiles in the detailed report…..
15. Early stage products (Phase I/II)
16. Genakumab: GeneScience Pharmaceuticals
17. Drug profiles in the detailed report…..
18. Inactive Products
19. Oropharyngeal Cancer Key Companies
20. Oropharyngeal Cancer Key Products
21. Oropharyngeal Cancer- Unmet Needs
22. Oropharyngeal Cancer- Market Drivers and Barriers
23. Oropharyngeal Cancer- Future Perspectives and Conclusion
24. Oropharyngeal Cancer Analyst Views
25. Oropharyngeal Cancer Key Companies
26. Appendix
Get to know more information about the Oropharyngeal Cancer Emerging Drugs and Companies of the report @ https://www.delveinsight.com/sample-request/oropharyngeal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Trending Market Research Reports 2032 | DelveInsight
Technical Due Diligence Firms- https://www.delveinsight.com/consulting/due-diligence-services
Vital Sign Monitors Devices Market- https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
Stem Cell Market- https://www.delveinsight.com/report-store/stem-cell-market
Anastomosis Device Market- https://www.delveinsight.com/report-store/anastomotic-leak-devices-market
Asperger Syndrome Market- https://www.delveinsight.com/report-store/asperger-syndrome-market
B-Cell Maturation Antigen Targeted Therapies Market- https://www.delveinsight.com/report-store/b-cell-maturation-antigen-targeted-therapies-market
UK Healthcare Report- https://www.delveinsight.com/report-store/uk-healthcare-outlook-report
Oncolytic Virus Cancer Therapy Pipeline- https://www.delveinsight.com/report-store/oncolytic-virus-cancer-therapy-pipeline-insight-2021
Shingles Market- https://www.delveinsight.com/report-store/shingles-market
Progressive Supranuclear Palsy Market- https://www.delveinsight.com/report-store/progressive-supranuclear-palsy-market
Tay-Sachs Disease Market- https://www.delveinsight.com/report-store/tay-sachs-disease-market
Shigellosis Market- https://www.delveinsight.com/report-store/shigellosis-market
Gene Therapy In CNS Disorder Market- https://www.delveinsight.com/report-store/gene-therapy-in-cns-disorder-market
Hypertrophic Cardiomyopathy Market- https://www.delveinsight.com/report-store/hypertrophic-cardiomyopathy-market
Varicella Zoster (HHV-3) Infections Market- https://www.delveinsight.com/report-store/varicella-zoster-hhv-3-infections-market
Vasculitis Market- https://www.delveinsight.com/report-store/vasculitis-market
Vascular Imaging Devices Market- https://www.delveinsight.com/report-store/vascular-imaging-market-market
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oropharyngeal cancer Pipeline Appears Robust With 10+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight here
News-ID: 2901012 • Views: …
More Releases from DelveInsight Business Research
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for Oropharyngeal
Oropharyngeal Cancer Market
Introduction
Oropharyngeal cancer (OPC) is a type of head and neck cancer that develops in the oropharynx, the part of the throat located at the back of the mouth. This cancer affects areas such as the tonsils, base of the tongue, and the soft palate, and it is closely linked to the human papillomavirus (HPV) infection. OPC is becoming an increasingly significant health concern, especially in regions like North America and…
Oropharyngeal Cancer Market Future Business Opportunities 2025-2032 |Innate Phar …
Latest Report, titled "Oropharyngeal Cancer Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by CoherentMI offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The oropharyngeal cancer market is estimated to be valued at USD 2.11 Bn in 2024 and is expected to reach USD 3.05 Bn by 2031, growing at…
Oropharyngeal Airway Market Size 2024 to 2031.
Market Overview and Report Coverage
An oropharyngeal airway is a medical device used to maintain an open airway in unconscious patients. The device is placed in the mouth to prevent the tongue from obstructing the airway and ensure proper ventilation. The global oropharyngeal airway market is expected to grow at a CAGR of 11.90% during the forecasted period.
The increasing prevalence of respiratory diseases, emergency medical situations, and surgical procedures…
Human Papillomavirus-positive Oropharyngeal Cancer Market to Witness Growth by 2 …
DelveInsight's "Human Papillomavirus-positive Oropharyngeal Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Human Papillomavirus-positive Oropharyngeal Cancer, historical and forecasted epidemiology as well as the Human Papillomavirus-positive Oropharyngeal Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Human Papillomavirus-positive Oropharyngeal Cancer market report provides current treatment practices, emerging drugs, the market share of the individual therapies,…
Oropharyngeal Airway Market 2021 Growth, COVID Impact, Trends Analysis Report 20 …
Oropharyngeal Airway Market is thoroughly, accurate and comprehensively assessed in a report focusing on market dynamics, market competition, regional growth, segment analysis, and key growth strategies. Report buyers will have access to proven market figures including global market size in terms of revenue and volume.
(Get 15% Discount on Buying this Report)
A full report of Global Oropharyngeal Airway Market is available at: https://www.orionmarketreports.com/oropharyngeal-airway-market/57268/
The Oropharyngeal Airway key manufacturers in this market include:
• Well…
Oropharyngeal Global Cancer Market Research Report 2025
Oropharyngeal Cancer Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
Access more details about this report at: https://www.research2reports.com/report-medical-devices/oropharyngeal-cancer-market/80991
The report firstly introduced the Oropharyngeal Cancer basics: definitions, classifications, applications and…
